Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Practice Point
  • Published:

Can PSA nadir predict prostate cancer outcomes following radiotherapy?

Nature Clinical Practice Urology volume 3, pages 464–465 (2006)Cite this article

boxed-textRay ME et al. (2006) PSA nadir predicts biochemical and distant failures after external beam radiotherapy for prostate cancer: a multi-institutional analysis. Int J Radiat Oncol Biol Phys 64: 1140–1150

Background

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. American Society for Therapeutic Radiology and Oncology Consensus Panel (1997) Consensus statement: guidelines for PSA following radiation therapy. Int J Radiat Oncol Biol Phys 37: 1035–1041

  2. Rosser CJ et al. (2002) Prostate specific antigen bounce phenomenon after external beam radiation for clinically localized prostate cancer. J Urol 168: 2001–2005

    Article  CAS  Google Scholar 

  3. Horwitz EM et al. (2005) Definitions of biochemical failure that best predict clinical failure in patients with prostate cancer treated with external beam radiation alone: a multi-institutional pooled analysis. J Urol 173: 797–802

    Article  Google Scholar 

  4. Pickles T (2006) Prostate-specific antigen (PSA) bounce and other fluctuations: which biochemical relapse definition is least prone to PSA false calls? An analysis of 2030 men treated for prostate cancer with external beam or brachytherapy with or without adjuvant androgen deprivation therapy. Int J Radiat Oncol Biol Phys 64: 1355–1359

    Article  Google Scholar 

Download references

Acknowledgements

The synopsis was written by Sandra Ford, Associate Editor, Nature Clinical Practice.

Author information

Authors and Affiliations

  1. Radiation Oncology, Oncology, and Urology at the Johns Hopkins University School of Medicine,

    Danny Y Song & Theodore L DeWeese

  2. Johns Hopkins Hospital,

    Danny Y Song & Theodore L DeWeese

  3. Radiation Oncology, Oncology, and Urology,

    Danny Y Song & Theodore L DeWeese

  4. Department of Radiation Oncology and Molecular Radiation Sciences at the Johns Hopkins University School of Medicine,

    Danny Y Song & Theodore L DeWeese

  5. Johns Hopkins Hospital, Baltimore, MD, USA

    Danny Y Song & Theodore L DeWeese

Authors
  1. Danny Y Song
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Theodore L DeWeese
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Theodore L DeWeese.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Song, D., DeWeese, T. Can PSA nadir predict prostate cancer outcomes following radiotherapy?. Nat Rev Urol 3, 464–465 (2006). https://doi.org/10.1038/ncpuro0564

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ncpuro0564

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing